Alzheimer Disease
Alzheimer disease requires culturally attuned recruitment, retention, and adherence practices
Published in Drug Week, February 17th, 2006
"This analysis presents a recruitment, retention, and (treatment and/or research) adherence (RRA) best practices model for targeting Alzheimer disease and associated dementias (ADAD) impacting ethnically diverse populations. RRA practice involves many more factors beyond cultural considerations to be highlighted here," a scientist writing in the journal Alzheimer Disease & Associated Disorders reported.
"However, it is the cultural dimension where much is at stake, where there is the least comprehensive framework, and where the most ambiguity exists...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Week
Source: Drug Week (2006-02-17)
More Articles from Drug Week
- Clinical Trials
Cholesterol drug's safety reconfirmed in analysis of 49 clinical trials, developer reports - Drug Development
Allergy immunotherapeutic achieves primary efficacy and safety endpoints in phase II/III trial - Drug Development
Networking computers reduces time to help combat disease - Acute Bronchitis
Pelargonium sidoides root extract shown to shorten duration of acute bronchitis - Addiction Medicine
Most patients with cocaine use-associated enterocolitis recover, some develop peritonitis - Addiction Medicine
Review examines future advances in addiction treatment - More from this issue of Drug Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
